Effect of a trifluoromethyl ketone on the motility of proton pump-deleted mutant of Escherichia coli strain and its wild-type

In Vivo

Volumn 18, Issue 4, 2004, Pages 505-508

  Molnár, Annamaria ^a   Wolfart, Krisztina ^a   Kawase, Masami ^b   Motohashi, Noboru ^c   Molnár, Joseph ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b JOSAI UNIVERSITY   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Escherichia coli; Motility; Proton pump; Trifluoromethyl ketone

Indexed keywords

1 (2 BENZOXAZOLYL) 3,3,3, TRIFLUORO 2 PROPANONE; ANTIBIOTIC AGENT; KETONE DERIVATIVE; PROTON PUMP; TF 18; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM MUTANT; CONTROLLED STUDY; DELETION MUTANT; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE; WILD TYPE;

ESCHERICHIA COLI;

EID: 4444283910     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Begue J-P and Bonnet-Delpon D: Preparation of trifluoromethyl ketones and related fluorinated, ketones. Tetrahedron 47: 3207-3258, 1991.
2. Kawase M: Synthetic and medicinal chemistry of trifluoromethyl ketones. (in Japanese) J Synth Org Chem Japan 59: 755-765, 2001.
3. Kawase M, Sakagami H, Kusama K, Motohashi N and Saito S: α-Trifluoromethylacyloins induce apoptosis in human oral tumor cell lines. Bioorg Med Chem Lett 9: 3113-3118, 1999.
4. Kawase M, Sunaga K, Tani S, Niwa M and Uematsu T: Trifluoromethyl ketone-based inhibitors of apoptosis in cerebellar granule neurons. Biol Pharm Bull 24: 1335-1337, 2001.
5. Khanna IK, Weier RM, Yu Y, Collins PW, Miyashiro JM, Koboldt CM, Veenhuizen AW, Currie JL, Seibert K and Isakson PC: 1,2-Diarylpyrroles as potent and selective inhibitors of cylooxygenase-2. J Med Chem 40: 1619-1633, 1997.
6. Frey RR, Wada CK, Garland RB, Curtin ML, Michaelides MR, Li J, Pease LJ, Glaser KB, Marcotte PA, Bouska JJ, Murphy SS and Davidson SK: Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorg Med Chem Lett 12: 3443-3447, 2002.
7. Kawase M, Motohashi N, Sakagami H, Kanamoto T, Nakashima H, Ferenczy L, Wolfard K, Miskolci C and Molnár J: Antimicrobial activity of trifluoromethyl ketones and their synergism with promethazine. Int J Antimicrob Agents 18: 161-165, 2001.
8. Alföldi L, Rasko I and Kerekes E: L-Serine deaminase of E. coli. J Bacteriol 96: 1512-1518, 1968.
9. Molnár J, Ren J, Kristiansen JE and Nakamura MJ: Effects of some tricyclic psychopharmacons and structurally related compounds on motility of Proteus vulgaris. Autonie von Leeuwenhoek 62: 315-320, 1992.
10. Ren JK, Petofi S and Molnár J: Mechanisms of antimotility action of tricyclic compounds in Proteus vulgaris. Acta Microbiol Acad Sci Hung 40: 369-377, 1993.
11. Kawase M, Harada H, Saito S, Cui J and Tani S: In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones. Bioorg Med Chem Lett 9: 193-194, 1999.
12. Okusu H, Ma D and Nikaido H: AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178: 306-308, 1996.
13. Josenhans C and Suerbaum S: The role of motility as a virulence factor in bacteria. Int J Med Microbiol 291: 605-614, 2002.
14. Molnár J, Haszon I, Bodrogi T, Martonyi E and Turi S: Synergistic effect of promethazine with gentamycine in frequently recurring pyelonephritis. Int J Urol Nephrol 22: 405-411, 1990.
15. Mandi Y and Molnár J: Effect of chlorpromazine on conjugal plasmid transfer sex pili. Acta Microbiol Acad Sci Hung 28: 205-210, 1982.